Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05702671

Kenota 1 CWS Method Comparison Validation Study

Conditions: Allergy, Immunoglobulin E-Mediated Allergic Disorder

Sex: All
Ages: N/A – 80 Years
Healthy volunteers: 1
Enrollment: 360
Sponsor: Kenota Inc.

Location: United States

Summary

The goal of this Method Comparison Study is to compare total IgE results obtained from at least 360 subjects aged less than 80 years old using four different testing arms comprising three types of samples and two testing methods. The main questions it aims to answer are:Are the Kenota 1 Devices easy to use by untrained operators at a clinic environment?Do tIgE results provided by the Kenota 1 Devices match the results provided by the FDA-cleared Phadia ImmunoCAP System?Subjects will be asked to donate two fingerstick whole blood samples and one venous blood draw.

Eligibility Criteria

Inclusion Criteria:Ages <80 yearsFrom all Ethnic/Racial backgroundsExclusion Criteria:Individuals older than 80 years of ageIndividuals with skin damage, burns or scars at the site of venipuncture on both arms

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05702671). StuddyBuddy aggregates publicly available trial information.